ATE263170T1 - Gefässverschliessende substituierte 2,3- dihydro -1,4- dioxinopyridine - Google Patents

Gefässverschliessende substituierte 2,3- dihydro -1,4- dioxinopyridine

Info

Publication number
ATE263170T1
ATE263170T1 AT96903952T AT96903952T ATE263170T1 AT E263170 T1 ATE263170 T1 AT E263170T1 AT 96903952 T AT96903952 T AT 96903952T AT 96903952 T AT96903952 T AT 96903952T AT E263170 T1 ATE263170 T1 AT E263170T1
Authority
AT
Austria
Prior art keywords
dioxinopyridines
vaso
occlusive
dihydro
substituted
Prior art date
Application number
AT96903952T
Other languages
English (en)
Inventor
Lommen Guy Rosalia Eugene Van
Jose Ignacio Andres-Gil
Francisco Javi Fernandez-Gadea
Maria Enc Matesanz-Ballesteros
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE263170T1 publication Critical patent/ATE263170T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT96903952T 1995-02-07 1996-01-30 Gefässverschliessende substituierte 2,3- dihydro -1,4- dioxinopyridine ATE263170T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200290 1995-02-07
PCT/EP1996/000396 WO1996024596A1 (en) 1995-02-07 1996-01-30 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines

Publications (1)

Publication Number Publication Date
ATE263170T1 true ATE263170T1 (de) 2004-04-15

Family

ID=8219997

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903952T ATE263170T1 (de) 1995-02-07 1996-01-30 Gefässverschliessende substituierte 2,3- dihydro -1,4- dioxinopyridine

Country Status (16)

Country Link
US (1) US5990123A (de)
EP (1) EP0808316B9 (de)
JP (1) JP4093431B2 (de)
KR (1) KR100412070B1 (de)
AR (1) AR002959A1 (de)
AT (1) ATE263170T1 (de)
AU (1) AU692361B2 (de)
DE (1) DE69632032T2 (de)
ES (1) ES2218582T3 (de)
FI (1) FI113774B (de)
IL (1) IL117045A (de)
MY (1) MY113426A (de)
NO (1) NO315237B1 (de)
TW (1) TW446706B (de)
WO (1) WO1996024596A1 (de)
ZA (1) ZA96933B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6656950B2 (en) 2001-04-25 2003-12-02 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine
WO2002088132A1 (en) * 2001-04-26 2002-11-07 Wyeth Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-ht1aantagonists
WO2004106298A1 (en) * 2003-05-30 2004-12-09 Janssen Pharmaceutica N.V. Indole derivatives with an improved antipsychotic activity
WO2006034473A2 (en) * 2004-09-23 2006-03-30 Reddy Us Therapeutics, Inc. Novel pyrimidine compounds, process for their preparation and compositions containing them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254496B (it) * 1992-03-05 1995-09-25 Enichem Spa Preparazione di copolimeri alternati olefine/ossido di carbonio per mezzo di un catalizzatore eterogeneo supportato
ZA931343B (en) * 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
DE4226527A1 (de) * 1992-08-11 1994-02-17 Merck Patent Gmbh 1,4-Benzodioxanderivate

Also Published As

Publication number Publication date
FI113774B (fi) 2004-06-15
DE69632032D1 (de) 2004-05-06
DE69632032T2 (de) 2005-03-10
FI973245L (fi) 1997-08-06
ZA96933B (en) 1997-08-06
KR100412070B1 (ko) 2004-05-24
ES2218582T3 (es) 2004-11-16
EP0808316B9 (de) 2004-12-01
TW446706B (en) 2001-07-21
IL117045A0 (en) 1996-06-18
NO973624D0 (no) 1997-08-06
JP4093431B2 (ja) 2008-06-04
WO1996024596A1 (en) 1996-08-15
KR19980701921A (ko) 1998-06-25
EP0808316A1 (de) 1997-11-26
NO973624L (no) 1997-08-06
AU4785696A (en) 1996-08-27
AU692361B2 (en) 1998-06-04
EP0808316B1 (de) 2004-03-31
FI973245A0 (fi) 1997-08-06
US5990123A (en) 1999-11-23
AR002959A1 (es) 1998-05-27
MY113426A (en) 2002-02-28
IL117045A (en) 1999-03-12
NO315237B1 (no) 2003-08-04
JPH10513460A (ja) 1998-12-22

Similar Documents

Publication Publication Date Title
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK0771789T3 (da) 1 alpha, 26-dihydroxy-D-homo-vitamin D3
DE59609887D1 (de) Substituierte cyanophenyluracile
EE200000041A (et) Asendatud 1,2,3,4-tetrahüdronaftaleeni derivaadid
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
DE69618634D1 (de) 1,4-benzodioxin-derivate
NO984385D0 (no) Substituerte 1,2,3,4-tetrahydronaftalenderivater
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
DE59610332D1 (de) Substituierte aminouracile
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
BR9609319A (pt) Carbonilaminofeniluracilas substituídas
EP0811014A4 (de) Neuartiges bakteriozin, piscicolin 126
BR9608890A (pt) N-metilenotiouréias substituídas
ATE263170T1 (de) Gefässverschliessende substituierte 2,3- dihydro -1,4- dioxinopyridine
BR9603376A (pt) Tetrahidro-5-nitro-pirimidinas substituídas
ID16285A (id) Turunan-turunan 1,25-dihidroksi-16,22,23-trisdehidro-kolekalsiferol
DE59607732D1 (de) Substituierte benzylidencyanessigester
NO962931D0 (no) N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
ES1032571Y (es) Gafa,
DE59607958D1 (de) Substituierte phenyluracile
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
ITMI941593A1 (it) Tetraidropiridine 3, 3-disostituite

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties